EUVIMEDEUVIMED entdecken
Crossref

Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study

European Journal of Clinical Pharmacy · 20.12.2025 · 7 (1) · 6922-6927

DOI: 10.61336/ejcp/25-08-425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 20.12.2025.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Febrile seizures are the most common seizure disorder in children, typically presenting between 6 months and 5 years of age.

Objective

To assess the clinical spectrum, associated factors, and outcomes of febrile seizures in children. Methodology: This was a hospital-based retrospective analytical study conducted at Paediatrics Department of Shahida Islam Teaching Hospital Lodhran from June, 2025 to September, 2025, including 255 pediatric patients who presented with febrile seizures.

Results

The mean age was 24.6 ± 13.2 months, with complex febrile seizures occurring at a younger age (19.8 ± 12.7 vs 26.8 ± 12.9 months, p = 0.002). Complex seizures were associated with longer duration (15.6 ± 7.8 vs 4.2 ± 2.1 minutes), higher frequency of multiple episodes (59.7% vs 15.7%), and increased focal features (48.1% vs 6.7%) (p

Zitieren

APA

(2025). Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study. European Journal of Clinical Pharmacy, 7(1), 6922-6927. https://doi.org/10.61336/ejcp/25-08-425

Vancouver

Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study. European Journal of Clinical Pharmacy. 2025;7(1):6922-6927. doi:10.61336/ejcp/25-08-425

BibTeX
@article{euvimed2025,
  title = {Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study},
  journal = {European Journal of Clinical Pharmacy},
  year = {2025},
  volume = {7},
  number = {1},
  pages = {6922--6927},
  doi = {10.61336/ejcp/25-08-425}
}
Kostenlos starten →